June 28, 2022
Contrast media shortage reveals cracks in supply chain
May 2022 saw a critical shortage of the iodinated contrast medium (ICM) iohexol that extended well into June because of a COVID-19-related shutdown of a GE Healthcare plant in Shanghai, China, that interrupted the manufacture of ICM. According to the American College of Radiology, contrast media were added to the US Food and Drug Administration (FDA) drug shortage list on May 9.
Free Daily News
- Q1 reports show climb in outpatient surgical volume, diverging trends at Surgery Partners, Ardent Health
- Study: SGLT2 inhibitors raise postop euglycemic ketoacidosis risk but lower mortality
- FDA launches effort to identify, slash outdated healthcare regulations under 10-to-1 rule
- The Joint Commission, NFQ announce 2024 Eisenberg Award recipients
- Low-income patients billed despite hospital tax breaks
- Report: Global nurse shortage widens inequities, fuels migration risks
- Study: Machine learning quadruples delirium detection in hospitalized older adults
- Ice machines spread Legionella in hospital oncology unit, prompting testing overhaul
- FDA fast-tracks generative AI rollout amid growing safety concerns
- Surveyed nurses report widespread burnout, urge system-wide reform
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement